Abbott Laboratories (BVL:ABTUS)
Peru flag Peru · Delayed Price · Currency is PEN · Price in USD
92.80
+1.67 (1.83%)
At close: Apr 28, 2026

Abbott Laboratories Statistics

Total Valuation

BVL:ABTUS has a market cap or net worth of PEN 567.82 billion. The enterprise value is 588.33 billion.

Market Cap 567.82B
Enterprise Value 588.33B

Important Dates

The next estimated earnings date is Wednesday, July 15, 2026.

Earnings Date Jul 15, 2026
Ex-Dividend Date Apr 15, 2026

Share Statistics

Current Share Class 1.74B
Shares Outstanding n/a
Shares Change (YoY) +0.03%
Shares Change (QoQ) n/a
Owned by Insiders (%) 0.49%
Owned by Institutions (%) 81.10%
Float 1.73B

Valuation Ratios

The trailing PE ratio is 26.02 and the forward PE ratio is 16.46.

PE Ratio 26.02
Forward PE 16.46
PS Ratio 3.60
PB Ratio 3.08
P/TBV Ratio 7.21
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a

Enterprise Valuation

EV / Earnings 26.96
EV / Sales 3.71
EV / EBITDA 13.35
EV / EBIT 18.58
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.27
Debt / EBITDA 1.13
Debt / FCF n/a
Interest Coverage 17.60

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 11.99%
Return on Capital Employed (ROCE) n/a
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 1.37M
Profits Per Employee 189,784
Employee Count 122,000
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, BVL:ABTUS has paid 6.50 billion in taxes.

Income Tax 6.50B
Effective Tax Rate 22.87%

Stock Price Statistics

The stock price has decreased by -28.92% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -28.92%
50-Day Moving Average 130.02
200-Day Moving Average 130.77
Relative Strength Index (RSI) 4.26
Average Volume (20 Days) 1

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 1.85

Income Statement

In the last 12 months, BVL:ABTUS had revenue of PEN 157.56 billion and earned 21.83 billion in profits. Earnings per share was 12.46.

Revenue 157.56B
Gross Profit 88.97B
Operating Income 31.46B
Pretax Income 28.41B
Net Income 21.83B
EBITDA 42.42B
EBIT 31.46B
Earnings Per Share (EPS) 12.46

Balance Sheet

The company has 31.21 billion in cash and 49.35 billion in debt, giving a net cash position of -18.14 billion.

Cash & Cash Equivalents 31.21B
Total Debt 49.35B
Net Cash -18.14B
Net Cash Per Share n/a
Equity (Book Value) 184.22B
Book Value Per Share 104.79
Working Capital n/a

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Depreciation & Amortization 11.00B
Net Borrowing n/a
Free Cash Flow n/a
FCF Per Share n/a

Margins

Gross margin is 56.47%, with operating and profit margins of 19.97% and 13.91%.

Gross Margin 56.47%
Operating Margin 19.97%
Pretax Margin 18.03%
Profit Margin 13.91%
EBITDA Margin 26.92%
EBIT Margin 19.97%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 8.37, which amounts to a dividend yield of 9.19%.

Dividend Per Share 8.37
Dividend Yield 9.19%
Dividend Growth (YoY) -2.16%
Years of Dividend Growth 2
Payout Ratio n/a
Buyback Yield -0.03%
Shareholder Yield 9.15%
Earnings Yield 3.84%
FCF Yield n/a
Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2